What question did this study set out to answer?

The research aims to explore the significance and evolving role of measurable residual disease (MRD) in acute myeloid leukemia (AML).

March 7, 2026Medical SciencesOpen Access

Landscape of Measurable Residual Disease in Acute Myeloid Leukemia: From Molecular Detection to Clinical Practice

View Full Paper

Ask AI

Bookmark

Authors

This review demonstrates the role of MRD assessment in AML management, suggesting implications for treatment planning and patient outcomes.

The research aims to explore the significance and evolving role of measurable residual disease (MRD) in acute myeloid leukemia (AML).
Review of various MRD detection technologies and their sensitivities.
Discussion of MRD integration into clinical practice for treatment decisions.
Analysis of MRD’s influence on peri-transplant strategies.
MRD assessment is crucial for prognosis and tailoring treatment in AML.
Different detection methods vary in sensitivity and application in clinical settings.
MRD status affects decisions on conditioning, donor selection, and post-transplant interventions.

Qadir et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

This review demonstrates the role of MRD assessment in AML management, suggesting implications for treatment planning and patient outcomes.